SUZ12 and malignant peripheral nerve sheath tumor: Among the 12 patients with MPNST, 17% (2/12) had losses in TERT, 8% (1/12) had a loss at TP53, and 50% (6/12) had losses on 17q at SUZ12 (Figure 2—figure supplement 1).